In the BioHarmony Drug Report Database
Mesalamine
Apriso, Asacol, Asacol Hd, Canasa, Delzicol, Lialda, Pentasa, Rowasa, Sfrowasa (mesalamine) is a small molecule pharmaceutical. Mesalamine was first approved as Apriso on 1987-12-24. It is used to treat proctitis, sigmoid diseases, and ulcerative colitis in the USA. It is known to target peroxisome proliferator-activated receptor gamma. Pentasa’s patents are valid until 2030-05-01 (FDA).
Trade Name
|
Apriso, Asacol, Asacol Hd, Canasa, Delzicol, Lialda, Pentasa, Rowasa, Sfrowasa |
|---|---|
Common Name
|
mesalamine |
ChEMBL ID
|
CHEMBL704 |
Indication
|
proctitis, sigmoid diseases, ulcerative colitis |
Drug Class
|
Anti-inflammatory agents (salicylic acid derivatives) |
Image (chem structure or protein)